Precision BioSciences, Inc. Common Stock (DTIL) is a publicly traded Healthcare sector company. As of November 20, 2026, DTIL trades at $6.93 with a market cap of $271.01M and a P/E ratio of -4.89. DTIL moved +0.22% today. Year to date, DTIL is +69.71%; over the trailing twelve months it is +43.65%. Its 52-week range spans $3.53 to $11.29. Analyst consensus is buy with an average price target of $40.00. Rallies surfaces DTIL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
2 analysts cover DTIL: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $40.00.
| Metric | Value |
|---|---|
| Price | $6.93 |
| Market Cap | $271.01M |
| P/E Ratio | -4.89 |
| EPS | $-1.28 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.29 |
| 52-Week Low | $3.53 |
| Volume | 8 |
| Avg Volume | 0 |
| Revenue (TTM) | $45.05M |
| Net Income | $-52.73M |
| Gross Margin | 0.00% |
2 analysts cover DTIL: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $40.00.